To further determine whether any of the mass spectrometry–identified CASP4/GSDMD secretomes, including cytokines and chemokines (36), are increased in HFD+CKD, we measured plasma cytokines and chemokines using a mouse cytokine array (Supplemental Figure 2). This evidence concerns the gene GSDMD and chronic kidney disease.